Objectives To implement and evaluate a dedicated receiver array coil for simultaneous positron emission tomography/ magnetic resonance (PET/MR) imaging in breast cancer. Methods A 16-channel receiver coil design was optimized for simultaneous PET/MR imaging. To assess MR performance, the signal-to-noise ratio, parallel imaging capability and image quality was evaluated in phantoms, volunteers and patients and compared to clinical standard protocols. For PET evaluation, quantitative 18 F-FDG PET images of phantoms and seven patients (14 lesions) were compared to images without the coil. In PET image reconstruction, a CT-based template of the coil was combined with the MR-acquired attenuation correction (AC) map of the phantom/patient.
Introduction
Recent developments in hardware technology [1] have enabled creation of simultaneous PET/MR imaging systems [2] [3] [4] . Although successfully applied in many oncologic applications, simultaneous PET/MR in breast cancer has so far been delayed due to the need for a dedicated breast coil that allows for prone positioning and achieves high image quality, as a precondition for state-of-the-art breast MRI [5] . However, the presence of MR-related hardware, such as a breast coil, in the PET field-of-view (FOV) causes significant attenuation of the 511 keV annihilation photons, therefore hampering PET image quality [6] . Studies have found the presence of MR head coils, which contain a substantial amount of plastic housing material, lead to a 13-19 % underestimation of the PET activity concentration if it is not accounted for during image reconstruction [7] . The attenuation effects for "lighter" or more "transparent" MR surface coils were only 4 % overall, but up to 10-15 % closer to the coil surface [8] . These results demonstrate that disregarding MR coils leads to substantial regional bias in PET quantification, illustrating the importance of accurately implementing the methodology for MR coil attenuation correction (AC) in simultaneous PET/MR applications. Even though MR coils are invisible in conventional MR-acquired AC maps, it has been shown that coil AC can be successfully implemented using a CT-based coil template fused with a patient's MR-based AC map [6, 9, 10] .
In this work we describe the design and implementation of a prototype 16-channel MR coil specifically developed for simultaneous PET/MR imaging in breast cancer. Our goal was to validate that state-of-the-art MR image quality can be achieved while simultaneously not restricting PET image quality and accurate quantification. Results of this study should provide methodological validation for future clinical studies of simultaneous PET/MR systems in breast cancer.
Materials and methods

PET/MR coil design
The design of the dedicated PET/MR breast coil was based on an MR-only breast coil [11] . It allowed for prone patient positioning. Sixteen coil elements were arranged around two cylinders. In order to minimize attenuation of PET photons due to high absorbing components along the line-of-response (LOR), electronics with a high "component density," such as preamplifiers, were moved away from the imaging FOV (Fig. 1a,b) .
Phantom studies
All PET/MR imaging studies were performed in a simultaneous PET/MR system (Biograph mMR, Siemens Healthcare, Erlangen, Germany). For phantom studies, two 1-liter plastic bottles were filled with Gd-DTPA-doped water and placed in the coil. For PET imaging experiments 75 MBq of 18 F-FDG was homogeneously diluted in each bottle. A rather large activity was used to accurately characterize the effect of the coil on PET images. MR performance measurements of the dedicated PET/MR coil were compared to a standard commercially-available MR-only breast coil (Rapid Biomedical GmbH, Rimpar, Germany) [11] . A 2D spoiled gradient echo sequence of the phantom bottles was acquired to generate signal-to-noise ratio (SNR) maps. The sequence was repeated with no radio frequency (RF) excitation power (flip angle 0°) for a noise measurement to assess the noise correlation of the receiver channels and calculate signal-to-noise ratio (SNR) maps [12] . Both measurements were also done for the MR-only coil.
For PET performance measurements, 4-min static emission examinations of the two 18 F-FDG-doped water bottles were acquired. For a quantitative measure of the tracer concentration, an AC map of the phantoms was obtained by using the system's implemented automatic tissue segmentation algorithm of a Dixon MR-acquisition [13] . To evaluate PET photon attenuation due to the coil in the PET FOV, five PET measurements were obtained: (i) without any coil present (reference data); (ii) with the prototype PET/MR coil; (iii) with only the PET/MR coil housing material; (iv) with a commercially available 16-ch MR-only coil [11] ; and (v) with a 7-ch MR-only coil (commercially available biopsy breast array coil, InVivo Corporation, Gainesville, Florida, USA).
Volunteer and patient studies Two female volunteers were imaged for MR evaluation without administering a contrast agent after signed informed consent was obtained. SNR maps as described above were acquired in one volunteer. To assess parallel MRI performance of the 16-ch PET/MR coil, a clinical routine breast MRI sequence (axial T2-weighted 2D-turbo spin echo (TSE) sequence with a TR/TE of 4650 ms/119 ms, 221 Hz/pixel BW, avg 2, matrix 384×384, pix spacing 1.0×1.0 mm 2 , acceleration factor 3, slice thickness 2 mm, 90 slices) was acquired with an acceleration factor (AF) of three (TA 7 min 23 s) and seven (TA 4 min 17 s) in the second volunteer.
Seven patients (mean age=49±17) with breast cancer underwent a PET/MR examination on the integrated wholebody scanner using the PET/MR breast coil after their clinical PET/CT. All patients gave informed consent and approval of the institutional review board and the radiation protection authorities was obtained. Patients were injected with 18 F-FDG radiotracer (mean dose=344±52 MBq) and imaged in the simultaneous PET/MR scanner for 101-175 min p.i. in prone positioning using the dedicated breast coil. The imaging protocol included an MR Dixon acquisition in coronal orientation (TR/TE 3.6 ms/2.46 ms, FA 10°, pixel bandwidth 965 Hz/pixel, TA 30 s, matrix 126×192×127, pixel spacing 2.3×2.3×2.6 mm 3 ) for AC, followed by a 15-min PET static emission examination in a single bed position. All PET images were reconstructed using a standard, supplier-provided ordered subset expectation maximization (OSEM3D) algorithm with four iterations and 21 subsets, to yield 127 axial slices with pixel spacing of 2.3×2.3×2.6 mm 3 . Simultaneously, clinical routine breast MRI was performed with the following sequences: axial T2-weighted 2D-TSE sequence (described above with AF=7) and a T1-weighted 3D-gradient echo sequence before and repeated four times after Gd-DTPA contrast agent injection (repeated at 90s, 180 s, 270 s, 360 s pi with imaging parameters TR/TE 4.9 ms/2.2 ms, FA 15°, bandwidth 360 Hz/pixel, TA 60s, matrix 352×350×160, pixel spacing 1.0×1.0×1.0 mm 3 , acceleration factor three). One patient was additionally examined in our institute's standard clinical setting on a 3 T MRI system (Ingenia 3.0 T, Philips, Best, The Netherlands) with the 7-ch MR-only coil using the same MR imaging protocol.
Coil attenuation correction
To account for photon attenuation and scatter in the PET images due to the PET/MR coil, a CT-based AC map of the coil was obtained [14] and added to the MR-acquired Dixonbased patient/phantom AC map [13] . For this purpose a CT image of the coil was acquired on the PET/CT system with a tube voltage/current of 120 kV/105 mA. A vendor (Siemens)-supplied Metal Artifact Reduction (MAR) reconstruction was used to reduce streaking artefacts. Conversion of Hounsfield units to linear attenuation coefficients for positron annihilation photons at 511 keV was achieved by bilinear mapping [14] . The coil AC map was re-sampled to match the resolution of the MR-acquired patient AC map (M p ). Co-registration of the template coil map M c and the on-the-fly-acquired patient/ phantom map M p was achieved by using a little marker (10-ml water-filled vial), visible on both maps and integrated at a fixed position in the coil (yielding M pc ) (Fig. 1c) . A single marker to determine the coil position along the head-foot dimension was sufficient for registration since the coil is in a fixed position along the left-right and anterior-posterior dimensions by being placed on the patient table.
Data analysis
For MR performance evaluation, the coil sensitivity was assessed by generating SNR and noise correlation maps from the phantom and volunteer data and comparing them to the 16-ch MR-only coil.
Phantom measurements
The effect of the MR coil PET data was first assessed by the overall PET photon loss count. This was measured by Fig. 1 Design and implementation of the dedicated PET/MR breast coil. Optimizations for PET performance are illustrated by a photograph of the coil electronics (a) and the corresponding attenuation correction (AC) map (b). Note that the plugs in Fig. 1a are shown in storage position (blue arrows); once plugged in, they are outside of the axial PET imaging FOV and therefore do not contribute to photon attenuation. Implementation of CT-template-based attenuation correction shown in Fig. 1c . The CT-acquired coil map M c and the MR-acquired phantom map M p were combined to M pc , using the MR visible marker indicating the coil position in M p . The resulting combined map M pc is used for attenuation correction in the PET image reconstruction algorithm comparing the total PET photon counts in the phantom emission experiment with and without the coil in the FOV. Data were compared for the dedicated PET/MR coil and MR-only coils. Second, the ability to recover PET image homogeneity and accurate SUV quantification using the implementation of the CT-based coil AC was evaluated. To this end, PET images were reconstructed using AC for: (i) phantoms only (M p ); and (ii) for phantoms and coil combined (M pc ). These images were normalized to a reference data set consisting of a PET acquisition without the coil present.
Human measurements
In the patient studies, PET images from the PET/MR system were reconstructed: i) without coil correction (M p ); and ii) using the combined AC map M pc . Images were judged qualitatively. The criteria for "good" image quality were lesion conspicuity and a homogeneous tracer distribution in the liver. Even though no true "gold standard" reference exists, quantitative lesion SUVs were reported for the M p and M pc of the reconstructed PET images. Volumes of interests (VOIs) were drawn around the lesions using a threshold of 50 % of the SUV max . For further analysis, the VOI mean SUV values were used.
Results
MR performance
As a measure of SNR performance, the noise correlation of the PET/MR breast coil yielded a mean [min, max] value of 0.068 [8.7e-4, 0.39]. Regional sensitivity is illustrated by the SNR map of the PET/MR coil as compared to the 16-ch MR-only coil in Fig. 2b . Profile plots through the phantom demonstrate the almost identical SNR in both coils (Fig. 2a) . Also, in vivo, the acquired SNR map yielded an appearance comparable to the 16-ch MR-only coil (Fig. 2c,d) . Overall, MR image quality of the clinical protocol sequences in the PET/MR patient study was qualitatively comparable to the clinical routine MRonly study (Fig. 3) .
PET performance
Phantom measurements
In the PET emission experiment, the presence of the PET/MR coil caused only a 15 % reduction in overall true counts compared to 20 % for MR-only coils. Of the 15 % PET photon reduction caused by the PET/MR coil presence, 8 % was found to be caused by the coil housing; the remaining attenuation must be attributed to the electronic components.
Neglecting the coil in the AC resulted in an underestimation of the SUV, as well as an appearance of heterogeneities in the phantom PET images, as compared to the reference data acquired without the coil present (Fig. 4a) . Reconstruction of PET images acquired with the coil present, but using M p only, yielded a mean SUV underestimation of 22 %. The use of the combined AC map M pc recovered accurate SUV values and improved image homogeneity (Fig. 4b) .
Human measurements
Also, in vivo, a qualitative improvement in visual image appearance was found after the coil was included in the AC map. This is demonstrated in the PET images of Fig. 5 by the recovery of an homogeneous tracer distribution in the liver as well as the recovery of small lesion conspicuity. A comparison of all 14 analyzed lesions showed a high correlation between PET reconstructed with M pc and with M p (R 2 =0.99, p-value< 0.001, Fig. 6a ). Quantitative analysis showed including the coil template in AC, i.e., using M pc rather than M p , resulted in an increase of the SUV in the lesion VOIs (normalized difference: mean±SD=21±9 %, Fig. 6b ). Even though the mean SUV increased for all 14 lesions of the seven patients, the actual increase showed substantial variability among patients, ranging from 2 % to 36 % (Fig. 6b) .
Discussion
In clinical breast MRI, dedicated coils are commercially available as biopsy or diagnostic coils featuring between 4 and up to 16 receiver channels. We chose a 16-ch design to support fast and high quality diagnostic MRI. Our evaluation of signal sensitivity and overall image quality in phantoms and first patients showed that using this coil results in state-of-the-art breast MRI in simultaneous PET/MR. A clear advantage of the 16-ch design was demonstrated by highly parallel image acquisition, which enabled a substantial reduction in image acquisition time without significant degradation in image quality.
In simultaneous PET operation, the presence of the MR coil in the PET FOV causes attenuation and scatter of 511 keV positron annihilation photons. Recent published studies have shown implementation of a commercially available 4-ch breast biopsy MR coil in simultaneous PET/MR [9, 10] . Overall attenuation of PET photons caused by the presence of the 4-ch coil was reported as 11 % [10] . In this study, we found for two MR-only breast coils with 7-ch and 16-ch designs a 20 % overall photon attenuation and a 15 % attenuation for the 16-ch PET/MR coil with electronics replaced outside of the PET line-of-response (LOR) space. Even though these results are important for characterising the effect of the specific MR coil presence on PET imaging, the overall attenuation within the range of these numbers is not a limiting factor for simultaneous PET/MR operation. More of a concern is the appearance of regional artefacts in PET images due to attenuation and scatter caused by the presence of the MR coil [7, 8, 10] . Since these regional effects might coincide with the lesion location, quantification of the lesion SUV might be significantly altered by the presence of the coil. Therefore, using the coil without any further clinical correction makes a huge difference. However, other groups have already demonstrated that these effects could be corrected using a CT-based template map of the coil in PET image reconstruction [6, 9, 10] . Similarly, in this study, we acquired a CT-based template map of the coil that was converted to attenuation values at the 511 keV photon energy by a standard bilinear mapping approach [14, 15] . Using the template method, our results showed that SUV underestimation could be reduced from 22 % to only 2 % in phantom experiments. This result is well within limits found by other groups; e.g., the template AC approach implemented for the 4-ch MR-only breast coil by Aklan et al. yielded accurate SUV quantification within 5 % [10] . PET image reconstruction only using a patient u-map shown in (a-c) exhibit a loss of signal intensity in the liver from the posterior towards the anterior (closer to coil) in the liver (white arrows in a, c). This artefact is corrected by using the coil-patient combined u-map (d-f). Especially in small lesions, the effect of including the coil attenuation correction can result in a conspicuous increase in lesion tracer activity (white arrow in b and e)
In patients, the implementation of the coil template in the attenuation map yielded a substantial increase in lesion SUV for all patients (mean increase for all lesions=21 %). In addition we observed a large variability of the SUV correction for individual lesions (ranging from 2 % to 36 %), especially for lesions with a low SUV. This suggests that a simple bias correction is not sufficient, but rather the integration of the coil-specific attenuation is mandatory in order to perform an optimal, patient-specific reconstruction. One limitation of this study is that we did not compare our coil-corrected lesion SUV values to a true "gold standard" reference. Even though such a comparison was obtained and validated in a phantom and a similar SUV increase was observed in vivo, inhomogeneous in vivo tracer distribution, such as high activity coming from the liver or myocardium, might influence the coil correction method.
Conclusion
We developed and evaluated a 16-ch breast coil specifically designed for simultaneous PET/MR imaging. Our results showed that by using this coil, state-of-the-art breast MRI was possible in the setting of simultaneous PET/MR. In quantitative PET imaging, using the coil without any further correction could alter lesion SUV quantification and, therefore, severely impact clinical operation. In a phantom, this bias could be largely corrected by using a CT-template map of the coil within the attenuation correction for PET image reconstruction; however, in vivo, the method needs further validation.
